The abstract is read at the publisher; the summary is JClub's.
Mitochondrial central dogma pathways—especially mitochondrial translation and the mitoribosome—show modest enrichment for ALS genetic risk (Padj = 0.044) in a European GWAS.
- Why it matters: It remains unclear which mitochondrial processes relate to ALS risk and whether mitochondrial pathway changes reflect cause, consequence, or both.
- What they did: Using MAGMA on 27,205 ALS cases and 110,881 controls, the study tested MitoCarta3.0 pathways hierarchically and integrated TWAS/SMR directionality with cell type–adjusted GSEA/GSVA in >1,500 post-mortem motor cortex and spinal cord samples plus iPSC-derived motor neurones.
- The result: ALS tissue showed higher mitochondrial gene expression in motor cortex, with OXPHOS and mitoribosome enriched beyond a global shift (PFDR = 0.027), while nuclear–mtDNA co-expression was more negative in ALS post-mortem tissues but opposite in iPSC-derived motor neurones.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.